Authors
S. A. Rozhnova
Candidate of Pharmaceutical Sciences, Assistant Professor, Head, Chair for Pharmacy1
A. V. Tsypkina
Postgraduate Student, Chair for Pharmacy1
1 - Pirogov Russian National Research Medical University (RNRMU)
Corresponding Author
Anastasia V. Tsypkina, e-mail: nastenka.tsypkina@mail.ru
Financing
The study had no sponsorship.
Conflict of interest
None declared.
Abstract
The article analyzes the results of the implementation of the program «Development of pharmaceutical and medical industry» for 2013-2020 concerning the range of portfolios of domestic manufacturers, and the introduction of reference drugs to the Russian market. Replenishment of anatomical and therapeutic groups, as well as the relationship between the state requests for drug provision and drugs introduced in the state register of medicines are studied.
Key words
The introduction of new drugs, the reference of the medicines, development strategy
DOI
References
1. Shcherbinina S. L. Sostojanie i perspektivy razvitija farmacevticheskoj otrasli Rossii v uslovijah krizisa [Condition and prospects of development of the pharmaceutical industry in Russia in a crisis]. Molodoj uchenyj [Young Scientist] 2015; (10.2): 142-146. (In Russ.)
2. Prikaz Ministerstva promyshlennosti i torgovli RF ot 23 oktjabrja 2009 g. ¹ 965 «Ob utverzhdenii Strategii razvitija farmacevticheskoj promyshlennosti Rossijskoj Federacii na period do 2020 goda» [Order of the Ministry of Industry and Trade of the Russian Federation of October 23, 2009 No. 965 «On approval of the Strategy for the development of the pharmaceutical industry of the Russian Federation for the period up to 2020»]. Available at: http://www.garant.ru/products/ipo/prime/doc/4089282/ (Cited 22.04.2018) (In Russ.)
3. Abramova M.B. O problemah i tendencijah razvitija rossijskogo farmacevticheskogo rynka [On the problems and development trends of the Russian pharmaceutical market]. Teoreticheskaja jekonomika [Theoretical Economics] 2018; (2): 106-112. (In Russ.)
4. Ivashhenko A.A, Kravchenko D.V. Koncepcija innovacionnogo razvitija otechestvennoj farmacevticheskoj otrasli [The concept of innovative development of the domestic pharmaceutical industry]. Remedium [Remedium] 2008; (5): 6-13. (In Russ.)
5. Davydova K.S. Original'nye i vosproizvedennye lekarstvennye sredstva – realii sovremennogo farmacevticheskogo rynka [Original and reproduced medicines – the realities of the modern pharmaceutical market]. Remedium [Remedium] 2011; (2): 73-74 (In Russ.)
6. Farmacevticheskij rynok Rossii – 2017 [Pharmaceutical market of Russia – 2017]. URL: http://www.dsm.ru/docs/analytics/june_2017_pharmacy_analysis.pdf (In Russ.)
7. Farmacevticheskij rynok v Rossii: itogi i perspektivy [Pharmaceutical market in Russia: results and prospects]. URL: https://gmpnews.ru/event/farmacevticheskij-rynok-v-rossii-itogi-i-perspektivy/ (Cited 02.05.2018) (In Russ.)
8. Farmacevticheskij rynok Rossii. Janvar' 2018 [Pharmaceutical market of Russia. January 2018]. URL: http://www.dsm.ru/docs/analytics/january_2018_pharmacy_analysis.pdf (In Russ.)